Maitreya Medicare Ltd
Incorporated in 2019, Maitreya Medicare Ltd is an integrated multispeciality hospital with primary secondary & tertiary care situated in Surat, Gujrat.[1]
- Market Cap ₹ 192 Cr.
- Current Price ₹ 283
- High / Low ₹ 400 / 111
- Stock P/E 101
- Book Value ₹ 47.3
- Dividend Yield 0.00 %
- ROCE 11.4 %
- ROE 6.67 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
8.40 | 55.73 | 48.14 | 38.38 | 44.90 | 44.41 | |
7.74 | 48.42 | 45.21 | 31.22 | 38.74 | 39.53 | |
Operating Profit | 0.66 | 7.31 | 2.93 | 7.16 | 6.16 | 4.88 |
OPM % | 7.86% | 13.12% | 6.09% | 18.66% | 13.72% | 10.99% |
0.04 | 0.46 | 0.44 | 0.52 | 0.22 | 0.44 | |
Interest | 0.31 | 0.79 | 0.76 | 0.57 | 0.74 | 0.75 |
Depreciation | 0.34 | 1.00 | 1.20 | 1.27 | 1.26 | 1.35 |
Profit before tax | 0.05 | 5.98 | 1.41 | 5.84 | 4.38 | 3.22 |
Tax % | 220.00% | 26.09% | 24.11% | 28.25% | 27.85% | 40.99% |
-0.06 | 4.41 | 1.07 | 4.19 | 3.17 | 1.90 | |
EPS in Rs | -60.00 | 4,410.00 | 1,070.00 | 8.45 | 4.68 | 2.80 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 40% |
3 Years: | -3% |
TTM: | -1% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 102% |
3 Years: | 24% |
TTM: | -40% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 106% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 24% |
3 Years: | 18% |
Last Year: | 7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Equity Capital | 0.01 | 0.01 | 0.01 | 4.96 | 6.78 | 12.09 |
Reserves | -0.05 | 4.36 | 5.48 | 3.82 | 18.08 | 19.98 |
12.13 | 14.24 | 12.38 | 11.59 | 9.46 | 3.53 | |
2.30 | 7.28 | 4.96 | 7.38 | 6.43 | 8.81 | |
Total Liabilities | 14.39 | 25.89 | 22.83 | 27.75 | 40.75 | 44.41 |
9.33 | 13.81 | 13.50 | 11.51 | 10.94 | 11.97 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.41 | 1.54 | 0.36 | 0.70 | 3.40 | 7.62 |
4.65 | 10.54 | 8.97 | 15.54 | 26.41 | 24.82 | |
Total Assets | 14.39 | 25.89 | 22.83 | 27.75 | 40.75 | 44.41 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
1.23 | 4.91 | 0.77 | 2.42 | -0.26 | ||
-12.17 | -5.63 | 0.16 | 0.36 | -5.57 | ||
11.88 | 1.51 | -2.61 | -1.34 | 10.00 | ||
Net Cash Flow | 0.94 | 0.79 | -1.68 | 1.43 | 4.18 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Debtor Days | 31.72 | 30.78 | 40.94 | 88.06 | 106.25 | 124.76 |
Inventory Days | 171.39 | 62.04 | 40.82 | 69.86 | 29.89 | 20.09 |
Days Payable | 558.61 | 230.96 | 221.25 | 317.85 | 149.43 | 116.36 |
Cash Conversion Cycle | -355.50 | -138.13 | -139.49 | -159.93 | -13.30 | 28.49 |
Working Capital Days | 0.87 | 4.13 | 17.44 | 38.90 | 69.34 | 68.63 |
ROCE % | 43.19% | 11.40% | 33.68% | 18.61% | 11.35% |
Documents
Announcements
-
Appointment
30 May 2025 - Consent received from Bhavesh Saraiya & Co. to act as Internal Auditor for FY 2025-26.
-
Change in Company Secretary/Compliance Officer
30 May 2025 - Maitreya Medicare Limited has informed about Change in Company Secretary/Compliance Officer
-
Outcome of Board Meeting
30 May 2025 - Maitreya Medicare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
-
Statement of deviation(s) or variation(s) under Reg. 32
30 May 2025 - No deviation in IPO fund use; Rs.1489.12L fully utilized as per prospectus for hospital and working capital.
-
Statement of deviation(s) or variation(s) under Reg. 32
23 May 2025 - Revised statement confirms no deviation in IPO fund utilization for H1 Sept 2024.
Annual reports
Concalls
-
Nov 2024Transcript PPT
-
May 2024TranscriptNotesPPT
-
Feb 2024Transcript PPT
Integrated Healthcare Provider[1] Maitreya Medicare offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Laparoscopic Surgery, Oncology, Neurosurgery, Spine Surgery, Neurology, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine, etc.